Digital pathology
Paige
Digital pathology AI applications for cancer pathology, including Paige Prostate.
Last updated: May 25, 2026
Back to directoryDoMore Diagnostics Histotype Px Colorectal medical AI product profile
Digital pathology biomarker that analyzes colorectal cancer histology slides to support recurrence and survival risk stratification for adjuvant-treatment review.
Digital pathology
Best fit
Oncology and pathology teams exploring AI-supported colorectal cancer risk stratification where results are reviewed alongside TNM staging, ctDNA, guidelines, and clinician judgment.
- Primary use case
- AI-powered digital biomarker for stage II and stage III colorectal cancer outcome prediction from routine H&E histology slides
- Audience
- Colorectal cancer pathology teams, oncology programs, translational research groups, and digital pathology platform users
- Risk level
- High
- Pricing signal
- Enterprise diagnostic, oncology, and platform-partner pricing; request current regional and integration terms.
- Official sources
- 4 official sources
Compare within workflow: Digital pathology · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
product-specific source-backed lens: These product-specific signals summarize what the cited sources imply before treating DoMore Diagnostics Histotype Px Colorectal as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Confirm CE-IVD or other local status for the exact version, market, stage II/III colorectal indication, and whether the deployment is diagnostic, research, or platform-enabled. |
|---|---|
| Privacy | Review slide upload, hosting, customer-contract data roles, platform-partner processing, retention, access controls, audit trails, and whether oncology data leaves the lab or hospital environment. |
| Evidence | Check validation studies, endpoint definitions, patient population, scanner/site diversity, calibration, and whether evidence supports the actual treatment decision under consideration. |
| Workflow | Best used as a tumor-board or oncology decision-support input where pathologists and oncologists review the biomarker beside conventional pathology, ctDNA, and guideline-based factors. |
Where DoMore Diagnostics Histotype Px Colorectal fits
DoMore Diagnostics describes Histotype Px Colorectal as a CE-IVD-marked deep-learning digital biomarker for stage II and III colorectal cancer prognosis using routine H&E slides, with published and ongoing validation work and integrations or partnerships with digital pathology platforms including PathAI, Sectra, Proscia, and Paige.
Not for: Treatment selection, chemotherapy de-escalation, or patient counseling without oncologist review, local validation, and regulatory or guideline fit for the jurisdiction.
What to verify before using DoMore Diagnostics Histotype Px Colorectal
- Whether Histotype Px Colorectal is cleared or CE-marked for the intended country, cancer stage, specimen, scanner, and diagnostic or research workflow.
- How the output is used with TNM stage, ctDNA, pathology review, oncology guidelines, tumor board decisions, and patient-specific treatment planning.
- Digital pathology platform availability, scanner compatibility, slide quality requirements, data retention, access controls, and report integration.
- Validation evidence for the target population, adjuvant chemotherapy context, recurrence endpoint, survival endpoint, calibration, and prospective clinical utility.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- www.domorediagnostics.com / products
- www.domorediagnostics.com / news / do-more-diagnostics-achieves-ce-mark-43lh6
- www.domorediagnostics.com / news / domore-diagnostics-pathai-partnership
- www.domorediagnostics.com / news / domore-esmo25
Related medical AI products
Digital pathology
Digital pathology
PathAI
AI-enabled digital pathology platform with image management and algorithm access.
Digital pathology
Ibex Medical Analytics
Clinical-grade AI pathology platform for cancer diagnostics and pathology workflow support.
Digital pathology
Proscia
Concentriq digital pathology platform that supports diagnostic, research, and AI-enabled pathology workflows.